Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Aubreyon Apr 05, 2015 3:14am

132 Views

Post# 23598028

lets not get paranoid about terms

My logic...The term TLD1433 is the formal name of the drug, Rutherrin is the name of the comercial trademark. Just as a acetylsalicylic acid is the formal name of the drug, aspirin. Of course they would use the formal name in an anouncement about a toxicology study.
The purpose of the meeting with HC was to prevent any misunderstandings.or confusion..
to define exactly what is expected from TLT to satisfy the clinical trial application.
cheers

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario